LianBio cotiza a 0.05 USD y tiene una capitalización bursátil de $6M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
LianBio, operates as a biotechnology company in China and other Asian countries. It offers medicines for cardiovascular, oncology, ophthalmology, and inflammatory disease indications. The company develops mavacamten for the treatment of obstructive hypertrophic cardiomyopathy, which is in Phase 3 EXPLORER-CN trial; TP-…
| Periodo | 2023-11 | 2023-08 | 2023-05 | 2023-03 |
|---|---|---|---|---|
| Real | $-0.22 | $-0.20 | $-0.22 | $-0.17 |
| Estimado | $-0.33 | $-0.28 | $-0.27 | $-0.25 |
| Sorpresa | +33.3% | +28.6% | +18.5% | +32.0% |
| Métrica | LIANY | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -42.4% | -40.4% | -2.0% |
| ROA | -34.5% | -32.0% | -2.5% |
| Current Ratio | 13.24 | 2.84 | +10.40 |
| Debt / Equity | — | 0.28 | — |